Physician profile
Sanjaya Kumar
NPI 1902982879
$2,842.88
in general payments reported to CMS, 2019-2025
24 companies · $343 in 2025
The $343 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.80 · 2020: $62.83 · 2022: $287 · 2023: $463 · 2024: $1,631 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028 · Travel and Lodging: $909 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,027.97 |
| Travel and Lodging | $909.00 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,477.25 | 2022-2024 | |
| Astellas Pharma US INC | $222.33 | 2019-2025 | Xtandi |
| Tolmar, INC. | $198.74 | 2023-2025 | Eligard, Jatenzo |
| Laborie Medical Technologies Corp. | $87.65 | 2023-2024 | |
| Antares Pharma, INC. | $87.32 | 2022-2025 | Xyosted |
| Halozyme INC | $86.67 | 2023 | |
| Myriad Genetic Laboratories, INC. | $76.32 | 2023 | Prolaris |
| Abbvie INC. | $68.25 | 2023-2025 | |
| Boston Scientific Corporation | $66.40 | 2023 | Rezum Generator, Moses 550 D\F\L |
| Ferring Pharmaceuticals INC. | $65.04 | 2024-2025 | Adstiladrin |
| Axonics, INC. | $61.31 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $53.18 | 2025 | Lynparza |
| Endo Pharmaceuticals INC. | $46.74 | 2023-2024 | Xiaflex, Aveed |
| C. R. Bard, INC. & Subsidiaries | $44.48 | 2023-2024 | Bard Urinary Drainage Bag |
| Livanova USA, INC. | $27.33 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $24.97 | 2025 | |
| Palette Life Sciences, INC. | $22.23 | 2022 | |
| Calyxo, INC. | $21.16 | 2025 | Cvac Aspiration System |
| Sumitomo Pharma America, INC. | $20.22 | 2025 | Orgovyx |
| Allergan, INC. | $18.73 | 2020 | |
| Dendreon Pharmaceuticals LLC | $18.50 | 2025 | Provenge |
| Amgen INC. | $16.77 | 2020 | |
| Teleflex LLC | $16.66 | 2025 | Barrigel |
| Pfizer INC. | $14.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjaya Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.